Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China · Delayed Price · Currency is CNY 22.04
-0.14 (-0.63%)
Mar 19, 2026, 3:00 PM CST
SHA:600285 Market Cap
SHA:600285 has a market cap or net worth of 12.49 billion as of March 18, 2026. Its market cap has increased by 8.67% in one year.
Market Cap
12.49B
Enterprise Value
11.69B
Revenue
3.78B
Ranking
n/a
PE Ratio
15.81
Stock Price
22.04
Market Cap Chart
Since January 2, 2001, SHA:600285's market cap has increased from 2.12B to 12.49B, an increase of 489.59%. That is a compound annual growth rate of 7.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 12.41B | 6.42% |
| Dec 31, 2025 | 11.66B | -6.54% |
| Dec 31, 2024 | 12.48B | 29.34% |
| Dec 29, 2023 | 9.65B | 31.14% |
| Dec 30, 2022 | 7.36B | -17.51% |
| Dec 31, 2021 | 8.92B | 85.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet Rhodiola Pharmaceutical Holding Co. | 14.13B |
| Shanghai Haoyuan Chemexpress | 14.10B |
| Shenzhen Chipscreen Biosciences | 13.70B |
| Beijing Aosaikang Pharmaceutical | 13.63B |
| Zhejiang Jingxin Pharmaceutical | 13.39B |
| Zhejiang Hisun Pharmaceutical | 12.31B |
| Guangdong Taienkang Pharmaceutical | 11.63B |
| Zhejiang Hisoar Pharmaceutical | 11.49B |